scispace - formally typeset
A

Adebowale Adeyemo

Researcher at National Institutes of Health

Publications -  342
Citations -  25855

Adebowale Adeyemo is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Population & Genome-wide association study. The author has an hindex of 62, co-authored 318 publications receiving 23152 citations. Previous affiliations of Adebowale Adeyemo include Loyola University Chicago & University of London.

Papers
More filters
Journal ArticleDOI

A genome-wide association search for type 2 diabetes genes in African Americans.

Nichole D. Palmer, +384 more
- 04 Jan 2012 - 
TL;DR: It is suggested that multiple loci underlie T2DM susceptibility in the African-American population and that these loci are distinct from those identified in other ethnic populations.
Journal ArticleDOI

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

Georg Ehret, +391 more
- 06 Oct 2011 - 
TL;DR: A genetic risk score based on 29 genome-wide significant variants was associated with hypertension, left ventricular wall thickness, stroke and coronary artery disease, but not kidney disease or kidney function, and these findings suggest potential novel therapeutic pathways for cardiovascular disease prevention.
Journal ArticleDOI

A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.

TL;DR: A genome-wide association study for type 2 diabetes (T2D) in Icelandic cases and controls is conducted, and it is found that a previously described variant in the transcription factor 7-like 2 gene (TCF7L2) gene conferred the most significant risk.
Journal ArticleDOI

Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes

Julius Gudmundsson, +79 more
- 01 Aug 2007 - 
TL;DR: Results from eight case-control groups demonstrate that this variant in TCF2 (HNF1β), a gene known to be mutated in individuals with maturity-onset diabetes of the young type 5, confers protection against type 2 diabetes.